RESUMO
OBJECTIVE: To estimate the indirect costs generated by adults with cancer in Mexico from 2002-2020. MATERIALS AND METHODS: Using information from national sources and the national cancer incidence from GLOBOCAN, we estimated income lost due to premature death (ILPD), short-term benefits (STBs), disability pensions (DPs), and opportunity costs for the carer (OCCs) generated by patients with cancer. Amounts were reported in Mexican pesos. RESULTS: We estimated 23 359 deaths and 216 679 new cases of cancer by 2020, which would be associated with a total indirect cost of 20.15 billion Mexican pesos. Men are expected to generate 54.9% of these costs. ILPD is expected to comprise the highest percentage of the cost (60%), followed by OCCs (22%), STBs (17%) and DPs (1%). CONCLUSIONS: From an economic perspective, the results emphasize the need to strengthen preventive interventions and early detection of cancer among adults to reduce its effect on the productivity of Mexico.
Assuntos
Efeitos Psicossociais da Doença , Custos de Cuidados de Saúde/estatística & dados numéricos , Gastos em Saúde/estatística & dados numéricos , Neoplasias/economia , Adolescente , Adulto , Cuidadores/economia , Feminino , Previsões , Humanos , Renda , Expectativa de Vida , Masculino , México/epidemiologia , Pessoa de Meia-Idade , Pensões , Adulto JovemRESUMO
Purpose Cancer in a country like Mexico is a challenge for the current health system and for public health. However, the statistics about cancer in Mexico are scarce, so epidemiologic surveillance needs to be improved. The objectives of this article were to describe the extent of cancer and to estimate the national burden of cancer through 2020. Materials and Methods To meet this objective, an analysis of secondary official sources was performed. The cancer cases through 2020 were estimated on the basis of trends in mortality and the projection of incident cases reported by GLOBOCAN. Results In 2013, cancer was the cause of 12.84% of all deaths in Mexico. It is projected that the prevalence of cancer will be 904,581 by 2017 and will reach 1,262,861 by early in the next decade (ie, 2020). Conclusion Available data for cancer are incomplete. The development and implementation of population-based cancer registries in Mexico are essential. Assessment of the future outlook of cancer in Mexico will provide awareness of future challenges and can help health systems prepare to face them.
Assuntos
Neoplasias/epidemiologia , Política Pública/tendências , Feminino , Seguimentos , Humanos , Masculino , México/epidemiologia , Neoplasias/mortalidade , Análise de SobrevidaRESUMO
Abstract Objective: To estimate the indirect costs generated by adults with cancer in Mexico from 2002-2020. Materials and methods: Using information from national sources and the national cancer incidence from GLOBOCAN, we estimated income lost due to premature death (ILPD), short-term benefits (STBs), disability pensions (DPs), and opportunity costs for the carer (OCCs) generated by patients with cancer. Amounts were reported in Mexican pesos. Results: We estimated 23 359 deaths and 216 679 new cases of cancer by 2020, which would be associated with a total indirect cost of 20.15 billion Mexican pesos. Men are expected to generate 54.9% of these costs. ILPD is expected to comprise the highest percentage of the cost (60%), followed by OCCs (22%), STBs (17%) and DPs (1%). Conclusions: From an economic perspective, the results emphasize the need to strengthen preventive interventions and early detection of cancer among adults to reduce its effect on the productivity of Mexico.
Resumen Objetivo: Estimar el costo indirecto generado por población mexicana adulta con cáncer en el periodo 2002-2020. Material y métodos: Utilizando información 2002-2013 de fuentes nacionales y de incidencia de GLOBOCAN, se estiman para 2002-2020 los ingresos perdidos por muerte prematura (IPMP), subsidios de corto plazo (SCP), pensiones de invalidez (PD) y costo de oportunidad del cuidador (COC) generados por pacientes con cáncer, reportándose montos en millones de pesos (mdp) mexicanos. Resultados: Se estiman 23 359 muertes y 216 679 casos nuevos de cáncer para 2020, con un costo indirecto total de 20 148 mdp, del cual 54.9% corresponde a hombres. IPMP contribuye en mayor medida (60%), seguida por COC (22%), SCP (17%) y PD (1%). Conclusiones: Los resultados apoyan, desde la perspectiva económica, la necesidad de robustecer el proceso de prevención y detección temprana de los cánceres en adultos para reducir su impacto en la productividad del país.